Fyodor Urnov is a professor in the Department of Molecular & Cell Biology and director of the Innovative Genomics Institute at the University of California, Berkeley in Berkeley, California.
Segment
Read More
17:26
The FDA Approved The First CRISPR-Based Therapy. What’s Next?
The first CRISPR gene-editing treatment is a cure for sickle cell disease. Are we on the cusp of a gene therapy revolution?
Segment
Read More
17:22
CRISPR Stops Rare Genetic Disease In New Human Trial
Gene-editing technique CRISPR may deliver new treatments for genetic diseases—and it’s already being tested on patients.